PPD Honored for Excellence in Employee Learning and Development

Pharmaceutical Product Development, LLC (PPD),
a leading global contract research organization, announced today it has
been named to Training magazine’s 2019
Training Top 125 list recognizing excellence in employee learning
and development.

This marks the eighth consecutive year PPD has been named to the
magazine’s list of top 125 businesses. The Training Top 125 is
determined by evaluating companies that demonstrate measurable results
in achieving business goals advanced by effective employee learning and
development initiatives.

Training
magazine also honored Amy Chapman, a principal learning specialist with
PPD, as a Top 5 Emerging Training Leader. The award recognizes training
professionals with two to 10 years of industry experience who have
demonstrated stellar leadership skills, business savvy and training
expertise.

“Employee engagement and growth are critical to PPD’s culture of high
performance on behalf of our pharmaceutical and biotechnology clients,”
said Jay Dixon, senior vice president of quality and enterprise learning
at PPD. “Providing best-in-class learning and development programs
ensures that our employees are well-equipped with the necessary skills
to perform at the highest level and help ensure client success.”

PPD and Chapman were recognized during the annual Training 2019
Conference & Expo at Disney’s Coronado Springs Resort in Orlando,
Florida.

“Being named to the Training Top 125 list for eight consecutive years
exemplifies how PPD’s learning and education mission provides
exceptional training for employees that drive the company’s efforts to
improve health,” said Lorri Freifeld, Training magazine’s
editor-in-chief. “PPD does this by fostering a best-in-class learning
culture with programs that proactively, measurably and efficiently
improve employee growth, readiness and performance.”

About PPD

PPD is a leading global contract research organization providing
comprehensive, integrated drug development, laboratory and lifecycle
management services. Our clients and partners include pharmaceutical,
biotechnology, medical device, academic and government organizations.
With offices in 48 countries and more than 21,000 professionals
worldwide, PPD applies innovative technologies, therapeutic expertise
and a firm commitment to quality to help clients and partners bend the
cost and time curve of drug development and optimize value in delivering
life-changing therapies to improve health. For more information, visit www.ppdi.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190227005527/en/

Leave a Comment